Roche has received European Commission approval for its Tecentriq drug in combination with Avastin and chemotherapy as an initial treatment for people with a specific type of lung cancer, the Swiss pharma company said on Friday.
from Reuters: Health https://ift.tt/2tUJB5c
via IFTTT
0 comments: